However, researches have shown that COX-2 was not expressed at rest and is upregulated in various cancers, including colorectal cancer, and its specific inhibitor can inhibit tumor cell growth (Ayiomamitis et al., 2019). Here, PTGS2 is linked to colorectal cancer.